Myeloma

Top Story

Will CAR T cells become first-line therapy for hematologic malignancies?

Will CAR T cells become first-line therapy for hematologic malignancies?
HemOnc Today, March 25, 2019
Cover Story

New indications may accelerate ‘explosion’ in CAR T-cell therapy, but more education still needed

HemOnc Today, March 25, 2019
Years of research into chimeric antigen receptor T-cell therapy for cancer treatment is finally paying dividends. When Renier J. Brentjens, MD, PhD, director of…
FDA News

FDA places partial clinical hold on venetoclax trials for multiple myeloma

March 19, 2019
The FDA placed a partial clinical hold on trials designed to evaluate venetoclax for the treatment of multiple myeloma, according to the drug’s manufacturer. The…
In the Journals

Expanded single cord blood unit decreases hematopoietic recovery time after transplantation

March 1, 2019
An ex vivo-expanded umbilical cord blood unit appeared safe and effective as a standalone hematopoietic stem cell graft, shortening time to neutrophil and platelet…
More Headlines »
CME ABIM MOC

Ace the Case: A 72-Year-Old, Healthy, and Asymptomatic Woman With Incidentally Diagnosed Leukemia

There is no commercial support for this activity.

This educational activity will discuss the management of a 72-year old, asymptomatic female with severe leukopenia…
More »
Video
Meeting News Coverage

VIDEO: Physicians must wait for STAMINA data to ‘really play out’ for posttransplant myeloma treatment

December 29, 2016
More »
Resource Centers
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME ABIM MOC

Ace the Case: A 72-Year-Old Man With Fatigue, Weight Loss, and Lymphocytosis

There is no commercial support for this activity.

This educational activity will review the diagnosis and management of a 72-year-old man with complaints of increasing…
More »